2012 (41 POSTS)
Proctor DM, Thompson CM, Suh M, Haws LC , Harris MA. 2012. Mode of action for intestinal carcinogenesis of ingested hexavalent chromium in mice. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
Topics: carcinogens , chromium , mode of action
Thompson CM , Hixon JG, Kopec AK, Harris MA, Proctor DM , Haws LC . Assessment of genotoxic potential of Cr(VI) in the mouse duodenum via toxicogenomic profiling. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
Topics: chromium , genotoxicity
Urban J , Rowlands JC, Budinsky R, Dombkowski A, Thompson CM , Thomas RS. A genomics-based benchmark dose analyses of relative potencies of dioxin-like compounds in primary rat hepatocytes. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
Topics: dioxin , genotoxicity
Wikoff D , DeVito M, Walker N, Hixon G, Harris M, Tachovsky A, Birnbaum L, Haws L . Application of machine learning in the development of a weighting framework for evaluating estimates of relative potency for dioxin-like compounds. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.
View Abstract
Topics: dioxin
O’Brien TJ, Hao D, Suh M, Proctor D, Thompson CM, Harris MA, Parsons BL, Meyers MB. 2012. K-ras codon 12 GGT to GAT mutation is not elevated in the duodenum of mice subchronically exposed to hexavalent chromium in drinking water. Presented at the Society of Toxicology’s 51st Annual Meeting, March 11-15, San Francisco, CA.
View Abstract
Topics: chromium , water
2011 (37 POSTS)
Thompson C , Perry C , Gaylor D, Tachovsky A, Burkhalter B, Haws L . Derivation of an oral reference dose and drinking water screening level for sulfolane using benchmark dose modeling. Presented at Society of Toxicology 50th Annual Meeting, Washington DC, March 2011.
View Abstract
Topics: benchmark dose estimation (BMD) , modeling , water
Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M , et al. Breast cancer bone metastasis prevalence and survival outcomes: A quantitative review of the literature. Presented at the 34th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, 2011.
Topics: Cancer
Jensen I , Helm T, Cyr P . Impact of dysphagia on U.S. hospital charges in patients with comorbid conditions. Abstract PGI9 , ISPOR 14th Annual European Congress, 2011.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Jensen I , Helm T, Cyr P . Impact of complications from dysphagia on hospital charges in the United States. Abstract PGI7 , ISPOR 14th Annual European Congress, 2011.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Oller A, Henderson RG . Bioaccessibility testing and its application to read-across for hazard assessment and risk characterisation of metals. Annual Meeting of the Belgian Society for Toxicology and Ecotoxicology (BelTox), 2011.
Topics: Metals
Robison TW . Toxicology in the nonclinical development of drugs and biologics. Pharmaceutical Education and Research Institute, Genetic Toxicology, Arlington, VA, October 2011.
Topics: drug development
Jiang X , Knutson K, Zwica L, Lee S-Y, Chen Q, Hong B, Zhong X, Hao W, et al. The University of Michigan Dioxin Exposure Study: Predictors of household dust PCDD, PCDF, and PCB concentrations. Presented at the 32nd International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2011, Brussels, Belgium, August 2011.
Topics: dioxin , PCBs
Jiang X , Zwica L, Knutson K, Towey T, Hedgeman E, Franzblau A, Chen Q, Lee S-Y, et al. Measurements of household dust concentrations of PCDDs, PCDFs, and PCBs from a community in Michigan, USA. Presented at the 32nd International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2011, Brussels, Belgium, August 2011.
Topics: community health , dioxin
Diliberto JJ, Sirinek L, Burkhalter B, Wikoff DS , Hixon G, Becker J, Patterson DG, Turner W, Tachovsky JA, Birnbaum LS, Haws LC . Endometriosis in a cohort of women living in the Kanawha River Valley in West Virginia: Blood levels of non-dioxin-like PCBs and relationship with BMI and age. Presented at Dioxin 2011, Brussels, Belgium, August 2011.
Topics: PCBs
Haws LC , DeVito MJ, Walker NJ,Harris MA, Tachovsky JA, Birnbaum LS, Farland WH, Wikoff DS . Development of a consensus-based weighting framework for evaluating estimates of relative potency for dioxin-like compounds that includes consideration of data from human cells. Presented at Dioxin 2011, Brussels, Belgium, August 2011.
Topics: dioxin
Haws LC , Fitzgerald L, Burkhalter B, Harris M, Wikoff DS . Assessment of the US EPA’s proposed toxicological values for TCDD for regulation of dioxin-like compounds in foods: Bridging the science divide in a global market. Presented at Dioxin 2011, Brussels, Belgium, August 2011.
Topics: dioxin , Food science
Thomas RS, Rowlands JC, Budinsky RA, Thompson CM, Urban JD , Dombkowski, A. 2011. Genomic approaches for relative potency assessment. Presented at Dioxin 2011, Brussels, Belgium, August 2011.
Topics: risk analysis , risk assessment
Wikoff DS, Thompson C, Walker N, DeVito M, Harris M, Birnbaum L, Haws L . Derivation of relative potency estimates using benchmark dose modeling: A case study with TCDF. Presented at Dioxin 2011, Brussels, Belgium, August 2011.
Topics: benchmark dose estimation (BMD)
Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M , et al. Prevalence of bone metastasis after breast, lung, and prostate cancers: A systematic and quantitative review of the literature. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.
Topics: Cancer
Lau EC, Steffey D, Legg JC, Watson HN, Mowat FS, Kelsh MA . The problem of missing data: Using imputation methods to facilitate oncology outcomes research. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.